Literature DB >> 16315137

Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis.

Grant A Ramm1, Richard G Ruddell.   

Abstract

While iron is a vital requirement for normal cellular physiology, excessive intestinal absorption of iron as seen in hemochromatosis leads to its deposition in parenchymal cells of various organs such as the liver, heart, and pancreas, resulting in cellular toxicity, tissue injury, and organ fibrosis. Cellular injury is induced by iron-generated oxyradicals and peroxidation of lipid membranes. In the liver, lipid peroxidation results in damage to hepatocellular organelles, such as mitochondria and lysosomes, which is thought to contribute to hepatocyte necrosis and apoptosis, and ultimately lead to the development of hepatic fibrogenesis. Hepatic stellate cells are central to the development of hepatic fibrosis, as they can be activated into collagen-producing myofibroblasts. Numerous potential stimuli associated with hepatic iron overload and iron-induced hepatocellular injury have been assessed in an attempt to explain stellate cell transformation in hemochromatosis. Stellate cell activation and fibrosis appear to be regulated by a series of events involving cellular interaction between resident and nonresident cells of the liver, the sequestration of free iron versus the transport and storage of mobilizable iron, and extracellular matrix remodeling as well as intracellular signaling events associated with inflammatory and fibrogenic cytokines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16315137     DOI: 10.1055/s-2005-923315

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  50 in total

Review 1.  Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.

Authors:  Dean P Jones; John J Lemasters; Derick Han; Urs A Boelsterli; Neil Kaplowitz
Journal:  Mol Interv       Date:  2010-04

Review 2.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

3.  Protective effects of caffeic acid phenethyl ester on iron-induced liver damage in rats.

Authors:  S Oktar; Z Yönden; M Aydin; S Ilhan; E Alçin; O H Oztürk
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

4.  In vivo magnetic resonance imaging of transgenic mice expressing human ferritin.

Authors:  Hoe Suk Kim; Hyun Jung Joo; Ji Su Woo; Yoon Seok Choi; Seung Hong Choi; Hyeonjin Kim; Woo Kyung Moon
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

5.  Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.

Authors:  Tahereh Rostami; Seyed Mostafa Monzavi; Hossein Poustchi; Ali Reza Khoshdel; Maryam Behfar; Amir Ali Hamidieh
Journal:  Int J Hematol       Date:  2020-10-08       Impact factor: 2.490

6.  Oxidative stress responses in Wistar rats on subacute exposure to pharmaceutical wastewater.

Authors:  Ali Sharif; Muhammad Ashraf; Aqeel Javeed; Aftab Ahmed Anjum; Muhammad Furqan Akhtar; Bushra Akhtar; Ammara Saleem
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-19       Impact factor: 4.223

7.  Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist.

Authors:  Marcel van Deuren; Joyce J C Kroot; Dorine W Swinkels
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

8.  Function of the hemochromatosis protein HFE: Lessons from animal models.

Authors:  Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

9.  The effect of iron depletion on chronic hepatitis C virus infection.

Authors:  Massimo Franchini; Giovanni Targher; Franco Capra; Martina Montagnana; Giuseppe Lippi
Journal:  Hepatol Int       Date:  2008-05-08       Impact factor: 6.047

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.